Financials
- Market Capitalization 69.52 B
- Employee 15 K
- Founded 1988
- CEO Leonard Schleifer
- Website www.regeneron.com
- Headquarter New York, United States
- FIGI BBG000C734W3
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
18.61
市销率
5.84
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 125 | VRTX Vertex Pharmaceuticals Incorporated - Common Stock | 480.25 USD | -1.06% | -9.39% | +7.94% | +1.53% | 121.89 B USD | ||
| 295 | ARGX argenx SE - American Depositary Shares | 876.25 USD | -0.16% | -5.71% | -1.84% | +54.53% | 54.23 B USD | ||
| 378 | RVMD Revolution Medicines, Inc. - Common Stock | 183.95 USD | -1.57% | -3.13% | +18.68% | +232.04% | 39.11 B USD | ||
| 386 | ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 288.06 USD | -3.58% | -8.97% | +1.82% | -9.10% | 38.46 B USD |